Who is sponsoring NCT05607576?

NCT05607576 is sponsored by Deborah Elder.

What drugs are being tested in NCT05607576?

Interventions in NCT05607576: Uncovered CGM during radiologic procedures.

Is NCT05607576 still recruiting?

NCT05607576 is currently completed. Last updated 6 May 2025.

Are results published for NCT05607576?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2025-05-06 · How we verify

NCT05607576

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Dexcom G6 for Total Pancreatectomy With Islet Autotransplantation (TPIAT) Patients

Completed NA Results posted Last updated 6 May 2025

What this trial tests

NA trial testing Uncovered CGM during radiologic procedures in Diabetes in 18 participants. Completed in 1 May 2024.

Timeline

1 March 2022

Primary endpoint
20 October 2023

1 May 2024

Quick facts

Lead sponsor	Deborah Elder
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	18
Start date	1 March 2022
Primary completion	20 October 2023
Estimated completion	1 May 2024
Sites	1 location across United States

Drugs / interventions tested

Uncovered CGM during radiologic procedures

Conditions studied

Diabetes — all drugs for Diabetes →

Sponsor

Deborah Elder

Who can join

Adults 11 to 25, any sex, with Diabetes. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Dexcom G6 Accuracy Post Radiation Exposure by Clark Error Analysis (Zone A and B %) Primary · 3 months

Blood Glucose levels (mg/dL) obtained by the Dexcom G6 sensor and transmitter compared to blood glucose levels (mg/dL) obtained by a handheld glucometer until the transmitter is changed. The Clarke Error Grid Analysis method was used to compare absolute values. Accuracy reported as percentage of comparators in Zone A and B.

error grid section A

Group	Value	95% CI
CGM Uncovered -Pre Radiation Exposures	806
CGM Uncovered - Post Radiation Exposure	1226
CGM Uncovered - Post Radiation Exposure >500 µGy	704
Handheld Clinical Glucometer	1715
Handheld Home Glucometer.	1020

error grid section B

Group	Value	95% CI
CGM Uncovered -Pre Radiation Exposures	606
CGM Uncovered - Post Radiation Exposure	570
CGM Uncovered - Post Radiation Exposure >500 µGy	187
Handheld Clinical Glucometer	1033
Handheld Home Glucometer.	329

error grid section C

Group	Value	95% CI
CGM Uncovered -Pre Radiation Exposures	6
CGM Uncovered - Post Radiation Exposure	7
CGM Uncovered - Post Radiation Exposure >500 µGy	5
Handheld Clinical Glucometer	56
Handheld Home Glucometer.	69

error grid section D

Group	Value	95% CI
CGM Uncovered -Pre Radiation Exposures	17
CGM Uncovered - Post Radiation Exposure	31
CGM Uncovered - Post Radiation Exposure >500 µGy	5
Handheld Clinical Glucometer	47
Handheld Home Glucometer.	15

Post Radiation Dexcom G6 Transmitter Functional Duration by Clark Error Analysis (Zone A and B %) Primary · 3 months

Transmitter functional duration is determined by time from TPIAT procedure and CGM placement (baseline) to time for Transmitter changed (approximately 3 months), Functionality is determined by analysis of Blood Glucose (mg/dL) in month groupings (0-1month, 1-2months, 2+ months from baseline. Blood Glucose levels (mg/dL) obtained by the Dexcom G6 sensor and transmitter compared to blood glucose levels (mg/dL) obtained by a handheld glucometer until the transmitter is changed. The Clarke Error Grid Analysis method was used to compare absolute values. Accuracy reported as percentage of comparator

error grid Zone A

Group	Value	95% CI
Uncovered - 0-1 Month Post TPIAT	2065
Uncovered - 1-2 Months Post TPIAT	446
Uncovered - 2+ Months Post TPIAT	226

error grid Zone B

Group	Value	95% CI
Uncovered - 0-1 Month Post TPIAT	1173
Uncovered - 1-2 Months Post TPIAT	128
Uncovered - 2+ Months Post TPIAT	61

error grid Zone C

Group	Value	95% CI
Uncovered - 0-1 Month Post TPIAT	16
Uncovered - 1-2 Months Post TPIAT	2
Uncovered - 2+ Months Post TPIAT	0

error grid Zone D

Group	Value	95% CI
Uncovered - 0-1 Month Post TPIAT	43
Uncovered - 1-2 Months Post TPIAT	10
Uncovered - 2+ Months Post TPIAT	1

Sponsor's own description

A single-center prospective trial on the effects of standard of care radiation exposure on the Dexcom G6 continuous glucose monitoring (CGM) device.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Diabetes

Currently open trials in the same condition.

NCT07272837 — Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass · recruiting
NCT07479134 — Production of Stem Cells for the Generation of Pancreatic Cells · NA · recruiting
NCT07441655 — Families Implementing Good Health Traditions for Life · NA · recruiting
NCT06724172 — CHIME: Comparing Health Interventions for Maternal Equity · NA · recruiting
NCT07417865 — ECHO Diabetes FQHC · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05607576 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Deborah Elder
Last refreshed: 6 May 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05607576.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing